In this context, the potential metabolic benefits of allulose in relation to GLP-1 are gaining attention
SC semaglutide 2.4 mg once a week, placebo, SC semaglutide 1.0 mg once a week for 68 weeks of weight loss efficacy and safety, each treatment group is combined with lifestyle interventions
This dual-action mechanism provides additional effects on appetite control, blood sugar regulation, and fat metabolism, which likely explains the greater results seen in clinical trials
Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial
In a randomized controlled trial, 107 subjects with chronic constipation received injections of neurotrophin-3 or placebo in one of several dosing schedules for four weeks